Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

C-phenyl 1-thioglucitol compound

A technology of thiosorbitol and compounds, applied in the fields of carbocyclic sugars, metabolic diseases, organic chemistry, etc., can solve the problem of strong inhibition without reports

Inactive Publication Date: 2009-07-08
TAISHO PHARMACEUTICAL CO LTD
View PDF16 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] So far, C-phenyl sorbitol derivatives having selective inhibitory activity against SGLT2 have been reported (see Patent Document 9), but C-phenyl 1-thiosorbitol derivatives that strongly inhibit both SGLT1 and SGLT2 not yet reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • C-phenyl 1-thioglucitol compound
  • C-phenyl 1-thioglucitol compound
  • C-phenyl 1-thioglucitol compound

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0106] The preparation method of intermediate (II)

[0107] The production methods of intermediates (II) and (VIII) necessary for the production of the compound (I) of the present invention are shown below. Among them, D 1 Indicates Li or MgBr, and other symbols have the same meaning as above.

[0108] 【Chemical 6】

[0109]

[0110] (17) Step 17 (Coupling)

[0111] Aryllithium reagents can be prepared by using organometallic reagents such as n-butyllithium, sec-butyllithium, and tert-butyllithium for intermediate compound (XXII). Compound (XXIII) can be obtained by adding thiolactone (XVI) thereto. The solvent used for the reaction at this time may, for example, be tetrahydrofuran, diethyl ether or toluene. The reaction temperature is -80°C to room temperature, preferably -78°C to -25°C.

[0112] (18) Step 18 (acid hydrolysis)

[0113] Compound (VIII) can be produced by hydrolyzing the acetal group in compound (XXIII) with hydrochloric acid, p-toluenesulfonic acid mo...

Embodiment

[0151] The present invention will be further described in detail below in conjunction with reference examples, examples and test examples.

reference example 1

[0153] Preparation of 2,3,4,6-tetra-O-benzyl-5-thio-D-glucono-1,5-lactone (compound (XVI))

[0154] 【chemical 8】

[0155]

[0156] (1) Preparation of tetrahydro-2H-pyran-2-yl 2,3,4,6-tetra-O-acetyl-5-thio-D-glucopyranose

[0157] To a solution of 2,3,4,6-tetra-O-acetyl-5-thio-D-glucopyranose (2.0 g, 5.49 mmoL) in chloroform (40 mL), add 3,4-dihydro-2H -pyran (1.5 mL, 16.5 mmoL) and p-toluenesulfonic acid monohydrate (104 mg, 0.549 mmoL), stirred at room temperature for 1 hour. Saturated aqueous sodium bicarbonate solution was added to the reaction liquid, followed by extraction with chloroform, and the organic layer was washed with saturated brine, and dried over anhydrous magnesium sulfate. After the desiccant was filtered off, the solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (hexane:ethyl acetate=1:1) to obtain the title compound (2.56 g) as a light yellow amorphous substance.

[0158] (2) ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A C-phenyl 1-thioglucitol compound represented by the formula (I), a pharmaceutically acceptable salt thereof, or a hydrate of the compound or the pharmaceutically acceptable salt. (I) wherein X represents a hydrogen atom or a C1-6 alkyl group; Y represents a C1-6 alkylene group or -O-(CH2)n- (n represents an integer ranging from 1 to 5); and Z represents -CONHR or -NHCONHR (provided that, when Z represents -NHCONHR, n is not 1), where R represents a C1-6 alkyl group substituted by 1 to 3 groups independently selected from a hydroxyl group and -CONH2; and R represents a hydrogen atom or a C1-6 alkyl group substituted by 1 to 3 groups independently selected from a hydroxyl group and -CONH2. The compound, the salt or the solvate can inhibit the SGLT1 activity to prevent the absorption of glucose or the like, or can inhibit both the SGLT1 activity and the SGLT2 activity to prevent the absorption of glucose or the like and excrete a urine sugar, and is therefore useful as a prophylactic or therapeutic agent for diabetes.

Description

technical field [0001] The present invention relates to sodium-dependent glucose cotransporter 1 (SGLT1) activity inhibitory involved in the absorption of glucose, etc. in the small intestinal epithelium, or sodium-dependent glucose cotransporter involved in renal glucose reabsorption in addition to this action 2 (SGLT2) activity-inhibiting C-phenyl 1-thiosorbitol compounds. Background technique [0002] If you have diabetes, your fasting blood sugar level should be above 126 mg / dL. In addition, even if the fasting blood sugar level is normal, if it shows a high blood sugar level of 140 to 200 mg / dL after a meal, it will be diagnosed as impaired glucose tolerance (hereinafter referred to as IGT (impaired glucose tolerance)). It is believed that delaying the onset of diabetes from IGT can reduce the risk of cardiovascular disorders, and some knowledge has been obtained to show this view. For example, in the Da Qing IGT and Diabetes Study (Da Qing IGT and Diabetes Study) con...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D335/02A61P3/10A61K31/382A61P43/00
CPCC07H7/04C07D335/02A61P13/12A61P19/06A61P25/00A61P25/02A61P27/02A61P3/04A61P31/00A61P3/06A61P43/00A61P5/50A61P7/02A61P7/10A61P9/04A61P9/10A61P9/12A61P9/14A61P3/10A61K31/382
Inventor 柿沼浩行大井隆宏小桥阳平桥本优子高桥仁美
Owner TAISHO PHARMACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com